|Articles|July 1, 2004

July 2004 - Part 1
Volume 10
Issue 7 Pt 1

Cost Impacts of Illness on Families and Society

Author(s)David Share, MD, MPH

Download PDF: Cost Impacts of Illness on Families and Society

Articles in this issue

over 21 years ago

Article

Potential Application of the National Kidney Foundation's Chronic Kidney Disease Guidelines in a Managed Care Setting

over 21 years ago

Article

Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs

over 21 years ago

Article

Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy

over 21 years ago

Article

Medical Management of Osteoporosis

over 21 years ago

Article

Prescribing Proton Pump Inhibitors for Initial Treatment of Acid-related Gastrointestinal Diseases in a Managed Care Population

over 21 years ago

Article

Using Guidelines to Improve Care of Patients With Chronic Kidney Disease

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Cost Impacts of Illness on Families and Society

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

Building Trust: Public Priorities for Health Care AI Labeling

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule